DOCMF Stock Chart & Stats
$0.98
$0.08(7.55%)
At close: 4:00 PM EDT
$0.98
$0.08(7.55%)
Day’s Range― - ―
52-Week Range$0.80 - $1.36
Previous CloseN/A
Volume3.24K
Average Volume (3M)6.22K
Market Cap
$933.55M
Enterprise Value$885.85M
Total Cash (Recent Filing)$180.30M
Total Debt (Recent Filing)$393.50M
Price to Earnings (P/E)28.9
Beta1.37
Next Earnings
Nov 19, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)0.02
Shares Outstanding968,011,200
10 Day Avg. Volume162
30 Day Avg. Volume6,225
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.68
Price to Sales (P/S)0.79
P/FCF Ratio5.22
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue1.16
Enterprise Value/Gross Profit2.03
Enterprise Value/Ebitda6.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)$10.59M
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSolid free cash flow and close alignment with operating cash flow indicate effective conversion of earnings into cash. This provides funding for investment, dividends, and debt reduction while improving resilience through a period of weaker revenue and profitability.
Improving LeverageThe sustained reduction in debt relative to equity improves financial flexibility and lowers balance-sheet risk compared with prior years. Although leverage remains meaningful, continued deleveraging can support greater resilience and broaden future capital-allocation options.
Operating Profit RecoveryThe rebound in operating margin shows that profitability has some capacity to recover after the sharp 2025 deterioration. If maintained, stronger operating earnings could improve cash generation, support reinvestment in the brand, and help rebuild returns over coming periods.
Bears Say
Multi-year Revenue DeclineRepeated annual revenue contraction points to a persistent demand or market-position challenge rather than a single weak quarter. Continued top-line pressure limits operating leverage, reduces investment capacity, and makes a durable recovery in earnings more difficult.
Profitability Remains DepressedProfitability remains well below earlier levels despite the 2026 operating-margin rebound. Lower gross and net margins leave less buffer against promotional pressure or cost increases, constrain internally funded growth, and indicate that earnings recovery is not yet fully established.
Volatile Cash GenerationStrong absolute cash flow is tempered by meaningful year-to-year volatility, including weaker operating cash flow in 2026 and a weak 2023 comparison. Uneven conversion can complicate debt reduction, dividends, and investment planning when sales and margins are under pressure.
Dr. Martens Plc News
DOCMF FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest stock price was $0.80 and its highest was $1.36 in the past 12 months.
What is Dr. Martens Plc’s market cap?
Dr. Martens Plc’s market cap is $933.55M.
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is Nov 19, 2026 which is in 72 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on May 19, 2026. The company reported $0.057 earnings per share for the quarter, missing the consensus estimate of $0.059 by -$0.003.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Overvalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Semiannually dividend of $0.023 which represents an annual dividend yield of 3.41%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate is <0.01.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 968,011,200 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of $0.057 in its last earnings report, missing expectations of $0.059. Following the earnings report the stock price went up 5.834%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in DOCMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Martens Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.62%
12-Months-Change
Fundamentals
Return on Equity
3.41%
Trailing 12-Months
Asset Growth
-1.40%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dr. Martens Plc
Dr. Martens plc is a global footwear enterprise that handles the entire process of conceiving, crafting, sourcing materials for, marketing, selling, and distributing its products. The company boasts a significant international presence, serving customers across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. Its extensive product range includes classic 'Originals' footwear, contemporary 'fusion' styles, children's shoes, and casual designs, alongside various accessories. All merchandise is offered exclusively under the renowned Dr. Martens brand. Established in 1945, Dr. Martens plc maintains its corporate headquarters in London, United Kingdom.
Technical Analysis
Ownership Overview
0.18% Insiders
8.38% Mutual Funds
― Other Institutional Investors
87.49% Public Companies and
Individual Investors